Why is Bliss GVS Pharma falling/rising?

As of 22-Jul, Bliss GVS Pharma Ltd is currently priced at Rs 158.80, reflecting a decrease of Rs 2.55 or 1.58%. The stock has been underperforming recently, having fallen for the last two days with a total decline of 1.61%. Despite opening with a gain of 2.26% today and reaching an intraday high of Rs 165.65, it also touched a low of Rs 157.6. The stock has shown strong performance over the past week and month, with returns of 2.82% and 14.86%, respectively, although it has underperformed the sector by 0.67% today. While the stock has generated a significant return of 46.63% over the past year, it is trading at a premium compared to its peers, and its profits have decreased by 19.5%, indicating potential concerns about sustainability despite its strong historical performance.
In the broader market context, the stock's recent short-term performance contrasts with the benchmark Sensex, which has declined by 0.47% over the past week and 0.27% over the past month. This suggests that while Bliss GVS Pharma has shown resilience in the near term, it is still facing challenges that have contributed to its recent price drop. The company's low debt-to-equity ratio and rising investor participation, with a notable increase in delivery volume, indicate some underlying strength, but the overall market sentiment and recent profit declines may be weighing on investor confidence.